Palvella Therapeutics Inc
(PVLA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 1,936 | 5,846 | 5,370 | 3,698 | 10,988 |
| Gross Profit | 1,936 | 5,846 | 5,370 | 3,698 | 10,988 |
| Operating Expenses | 17,447 | 17,365 | 17,538 | 16,028 | 18,445 |
| Operating Income | -15,511 | -11,519 | -12,168 | -12,330 | -7,457 |
| Other Income | 2,328 | 3,417 | 2,432 | 1,992 | 2,356 |
| Pre-tax Income | -13,183 | -8,102 | -9,736 | -10,338 | -5,101 |
| Net Income Continuous | -13,183 | -8,102 | -9,736 | -10,338 | -5,101 |
| Net Income | $-13,183 | $-8,102 | $-9,736 | $-10,338 | $-5,101 |
| EPS Basic Total Ops | -14.15 | -8.80 | -10.40 | -11.20 | -5.60 |
| EPS Basic Continuous Ops | -14.16 | -8.73 | -10.47 | -11.16 | -5.54 |
| EPS Diluted Total Ops | -14.15 | -8.80 | -10.40 | -11.20 | -5.60 |
| EPS Diluted Continuous Ops | -14.16 | -8.73 | -10.47 | -11.16 | -5.54 |
| EBITDA(a) | $-14,906 | $-10,944 | $-11,401 | $-11,747 | $-6,612 |